Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
19 September 2014
Header
Header image
News

News

EFPIA wants to put an end to the resale of stolen and counterfeit drugs in the legitimate supply chain
15 September 2014

(15 September 2014 - Brussels, Belgium): The pan-European medicines verification system that EFPIA, the European Federation of Pharmaceutical Industries and Associations, is currently implementing with [...] Read more

News

Report suggests regulatory system for medicines can be used more effectively
18 September 2014

A new report from Escher, the independent TI Pharma platform for regulatory innovation, shows that the current regulatory system for medicines in Europe could be used in [...] Read more

Events calendar

Events Calendar

EV Healthcheck Forum 2015
On 04/11/2014 (Brussels, Belgium )

This comes at a moment where health systems around the world are at a crossroads. Ageing population, increasing cost of technologies, unhealthy lifestyles, rising patient expectations… [...] Read more

Events Calendar

Health Driving Growth
On 15/10/2014 (Brussels, Belgium)

On 15 October 2014, EFPIA will host a public conference to discuss the best path towards a stronger healthier and more prosperous EU. #HealthyEU – Health Driving [...] Read more

What we are reading

What we are reading

"Silo mindset in cost analysis" - Thomas Cueni - Basler Zeitung
16 September 2014

The global debate surrounding the cost of the new hepatitis C drug Sovaldi is symptomatic of the fact that the health policy debate is generally too limited. The subject is far more complex than it appears at first glance. It is too simplistic to criticise the pharmaceutical industry (once again) for constantly demanding higher prices for new drugs. It is also too simplistic to lambast the authorities because the Swiss Federal Office of Public Health's strict constraints mean only a small number of patients get access to the drug. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail